2jdo: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Although the crystal structure of the anti-cancer target protein kinase B, (PKBbeta/Akt-2) has been useful in guiding inhibitor design, the closely, related kinase PKA has generally been used as a structural mimic due to, its facile crystallization with a range of ligands. The use of, PKB-inhibitor crystallography would bring important benefits, including a, more rigorous understanding of factors dictating PKA/PKB selectivity, and, the opportunity to validate the utility of PKA-based surrogates. We, present a "back-soaking" method for obtaining PKBbeta-ligand crystal, structures, and provide a structural comparison of inhibitor binding to, PKB, PKA, and PKA-PKB chimera. One inhibitor presented here exhibits no, PKB/PKA selectivity, and the compound adopts a similar binding mode in all, three systems. By contrast, the PKB-selective inhibitor A-443654 adopts a, conformation in PKB and PKA-PKB that differs from that with PKA. We, provide a structural explanation for this difference, and highlight the, ability of PKA-PKB to mimic the true PKB binding mode in this case.
Although the crystal structure of the anti-cancer target protein kinase B (PKBbeta/Akt-2) has been useful in guiding inhibitor design, the closely related kinase PKA has generally been used as a structural mimic due to its facile crystallization with a range of ligands. The use of PKB-inhibitor crystallography would bring important benefits, including a more rigorous understanding of factors dictating PKA/PKB selectivity, and the opportunity to validate the utility of PKA-based surrogates. We present a "back-soaking" method for obtaining PKBbeta-ligand crystal structures, and provide a structural comparison of inhibitor binding to PKB, PKA, and PKA-PKB chimera. One inhibitor presented here exhibits no PKB/PKA selectivity, and the compound adopts a similar binding mode in all three systems. By contrast, the PKB-selective inhibitor A-443654 adopts a conformation in PKB and PKA-PKB that differs from that with PKA. We provide a structural explanation for this difference, and highlight the ability of PKA-PKB to mimic the true PKB binding mode in this case.


==Disease==
==Disease==
Line 19: Line 19:
[[Category: Barford, D.]]
[[Category: Barford, D.]]
[[Category: Collins, I.]]
[[Category: Collins, I.]]
[[Category: Davies, T.G.]]
[[Category: Davies, T G.]]
[[Category: Garrett, M.D.]]
[[Category: Garrett, M D.]]
[[Category: Graham, B.]]
[[Category: Graham, B.]]
[[Category: Hamlett, C.C.F.]]
[[Category: Hamlett, C C.F.]]
[[Category: Jhoti, H.]]
[[Category: Jhoti, H.]]
[[Category: Mchardy, T.]]
[[Category: Mchardy, T.]]
[[Category: Saalau-Bethell, S.]]
[[Category: Saalau-Bethell, S.]]
[[Category: Verdonk, M.L.]]
[[Category: Verdonk, M L.]]
[[Category: Woodhead, S.J.]]
[[Category: Woodhead, S J.]]
[[Category: Workman, P.]]
[[Category: Workman, P.]]
[[Category: EDO]]
[[Category: EDO]]
Line 40: Line 40:
[[Category: wnt signaling pathway]]
[[Category: wnt signaling pathway]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:44:33 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:02:07 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA